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BACKGROUND & AIMS: Hepatic gluconeogenesis provides fuel
during starvation, and is abnormally induced in obese in-
dividuals or those with diabetes. Common metabolic disorders
associated with active gluconeogenesis and insulin resistance
(obesity, metabolic syndrome, diabetes, and nonalcoholic fatty
liver disease) have been associated with alterations in iron
homeostasis that disrupt insulin sensitivity and promote dis-
ease progression. We investigated whether gluconeogenic sig-
nals directly control Hepcidin, an important regulator of iron
homeostasis, in starving mice (a model of persistently activated
gluconeogenesis and insulin resistance). METHODS: We inves-
tigated hepatic regulation of Hepcidin expression in C57BL/6Crl,
129S2/SvPas, BALB/c, and Creb3l3–/– null mice. Mice were fed a
standard, iron-balanced chow diet or an iron-deﬁcient diet for 9
days before death, or for 7 days before a 24- to 48-hour starvation
period; liver and spleen tissues then were collected and analyzed
by quantitative reverse-transcription polymerase chain reaction
and immunoblot analyses. Serum levels of iron, hemoglobin,
Hepcidin, and glucose also were measured. We analyzed human
hepatoma (HepG2) cells and mouse primary hepatocytes to study
transcriptional control of Hamp (the gene that encodes Hepcidin)
in response to gluconeogenic stimuli using small interfering RNA,
luciferase promoter, and chromatin immunoprecipitation ana-
lyses. RESULTS: Starvation led to increased transcription of the
gene that encodes phosphoenolpyruvate carboxykinase 1 (a
protein involved in gluconeogenesis) in livers of mice, increased
levels of Hepcidin, and degradation of Ferroportin, comparedwith
nonstarved mice. These changes resulted in hypoferremia and
iron retention in liver tissue. Livers of starved mice also had
increased levels of Ppargc1a mRNA and Creb3l3 mRNA, which
encode a transcriptional co-activator involved in energy meta-
bolism and a liver-speciﬁc transcription factor, respectively.
Glucagon and a cyclic adenosinemonophosphate analog increased
promoter activity and transcription ofHamp in cultured liver cells;
levels of Hamp were reduced after administration of small inter-
fering RNAs against Ppargc1a and Creb3l3. PPARGC1A and
CREB3L3 bound the Hamp promoter to activate its transcription
in response to a cyclic adenosine monophosphate analog.
Creb3l3–/– mice did not up-regulate Hamp or become hypo-
ferremic during starvation. CONCLUSIONS: We identiﬁed a link
between glucose and iron homeostasis, showing that Hepcidin is
a gluconeogenic sensor in mice during starvation. This response
is involved in hepatic metabolic adaptation to increased energy
demands; it preserves tissue iron for vital activities during food
withdrawal, but can cause excessive iron retention and hypo-
ferremia in disorders with persistently activated gluconeogen-
esis and insulin resistance.
Keywords: Peroxisome Proliferator-Activated Receptor-Gamma
Co-activator 1-Alpha (PGC1A); cAMP Response Element-Binding
Protein-H (CREBH); Glucagon; Mouse Model.
Adaptation to different states, such as exercise, rest,and starvation or overnutrition, is essential for life.
In turn, dysfunction and perturbation of these networks can
lead to metabolic imbalances, which if uncorrected induce
diseases such as obesity or diabetes. Metabolic adaptation
is largely controlled by transcriptional co-regulators and
transcription factors responsible, respectively, for sensing
metabolic disturbances and ﬁne-tuning the transcriptional
response.1 During starvation, this adaptive response is
essential for species survival, and the liver plays a central role
in this process as a main site for gluconeogenesis and energy
production.2 At early stages, the liver mobilizes glucose from
its glycogen stores; as fasting progresses, it oxidizes fat to
provide both energy for gluconeogenesis and substrate for
ketogenesis. Generation of sugar from nonsugar carbon sub-
strates (gluconeogenesis) involves several enzyme-catalyzed
reactions that take place in both cytosol and mitochondria.
Iron is essential for vital redox activities in the cell, in
particular it is required for respiration and energy produc-
tion in mitochondria (which are also the unique site for heme
synthesis and the major site for Fe-S cluster biosynthesis),
and likewise is important for mitochondria biogenesis.3
A number of iron abnormalities, ranging from low serum
iron/iron-restricted anemia to hepatic/systemic iron over-
load, have been reported in human disorders with activated
gluconeogenic signaling pathways, including obesity,4
metabolic syndrome,5–7 and diabetes.8,9 Interestingly, iron
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excess has been associated with worsened insulin sensitivity
and disease progression, whereas iron removal has been
found to be beneﬁcial.6,8,10 Based on these premises, we
asked whether iron status could be regulated directly by
gluconeogenic signals.
Systemic and local iron status are under the control of
hepcidin, a defensin-like circulating peptide that degrades
the iron exporter ferroportin (FPN1), thereby dictating the
extent of iron release or retention in the cell.11 Hepcidin
expression is transcriptionally controlled by a number of
factors that deliver the relevant stimulatory or inhibitory
signals to the nuclear machinery and turn on or off the
hepcidin (HAMP) gene. The main stimulatory transcription
factors include small mother against decapentaplegic
(SMAD) proteins, which bind the bone morphogenetic pro-
tein responsive element and deliver the “iron signal,”12,13
STAT-3, mainly involved in the inﬂammatory signal,14–16
and cyclic adenosine monophosphate (cAMP) response
element binding protein 3–like 3, CREB3L3 (also known as
CREBH), more recently found to mediate hepcidin induction
by endoplasmic reticulum (ER) stress17 triggered by a vari-
ety of physiological and pathophysiological states.18–20
Therefore, we focused on investigating the regulation of
hepcidin expression in the liver in response to gluconeo-
genic stimuli. To this end, we studied mice undergoing
prolonged starvation, a classic model of persistently acti-
vated gluconeogenesis and insulin resistance.
Materials and Methods
Animal Studies
The starvation experiment was as follows: 8- to 10-week-
old male C57BL/6Crl, 129S2/SvPas, BALB/c wild-type mice,
and Creb3l3-/- null mice (The Jackson Laboratory, Bar Harbor,
ME) were allowed free access to water and fed a standard, iron-
balanced chow diet in pellets (2018S Teklad Global 18%
Protein Rodent Diet; Harlan Laboratories, (San Pietro Al Nati-
sone, UD, Italy); iron content, 225 mg/kg) or starved up to 48
hours starting at the beginning of the light cycle.
Iron-deﬁcient diet experiments were as follows: 8-week-old
male C57BL/6Crl wild-type mice were fed an iron-deﬁcient diet
(ssniff EF R/M Iron Deﬁcient; Charles River, Calco, LC, Italy;
iron content, <10 mg/kg) for 9 days before death, or for 6 days
before the 24- to 48-hour starvation period.
All animals received humane care according to the criteria
outlined by the Federation of European Laboratory Animal Sci-
ence Associations. The study was approved by the Ethics Com-
mittee for Animal Studies at the University of Modena and
Reggio Emilia.
Blood Measurements and Tissue
Iron Content
Serum iron, serum ferritin (Tina-quant Ferritin kit; Roche
Diagnostics, Milan, Italy), hemoglobin, and glucose were
determined using an automated COBAS C501 counter (Roche,
Milan, Italy) at the clinical-chemical laboratory of the University
Hospital of Modena. Serum hepcidin was determined using an
enzyme-linked immunosorbent assay kit (USCN Life Science,
Hubei, China) according to the manufacturer’s instructions, as
previously reported.9 Serum ketone bodies were analyzed us-
ing a b-Hydroxybutyrate Assay Kit (Sigma-Aldrich, Milan, Italy)
following the manufacturer’s instructions.
Liver and spleen tissue specimens were analyzed for non-
heme iron content as previously reported.21
Real-Time Quantitative Reverse-
Transcription Polymerase Chain
Reaction and Semiquantitative
Reverse-Transcription Polymerase
Chain Reaction
Total cellular RNA was obtained by incubating cells in
iScript quantitative reverse-transcription polymerase chain
reaction (qRT-PCR) Sample Preparation Reagent (Bio-Rad,
Milan, Italy) according to the manufacturer’s instructions. Total
hepatic RNA was extracted as described.17 Complementary
DNA was generated by reverse transcription of 2 mL of iScript
buffer (for cultured cells) or 1 mg (for liver) with 200 U
ImProm-II Reverse Transcriptase (Promega, Milan, Italy)
following the manufacturer’s instructions. Expression of mRNA
was analyzed using SsoFast EvaGreen Supermix (Bio-Rad).
Primer sequences are listed in Supplementary Table 1. Cycling
conditions were as follows: 30 seconds at 98!C, followed by 40
cycles of 2 seconds at 98!C and 10 seconds at 60!C. After 40
ampliﬁcation cycles, threshold cycle values were calculated
automatically using the default settings of the CFX Manager
software (version 2.0; Bio-Rad), and femtograms of starting
complementary DNA were calculated from a standard curve
covering a range of 5 orders of magnitude. At the end of the
PCR run, melting curves of the ampliﬁed products were ob-
tained and used to determine the speciﬁcity of the ampliﬁca-
tion reaction. In each experiment, the change of speciﬁc mRNA
expression was reported as the fold increase as compared with
that of control cells or mice. Normalization of qRT-PCR data
was based on RPL19 housekeeping mRNA expression after
validation using the target stability value obtained from the
CFX Manager software (version 2.0; Bio-Rad).22 X-box binding
protein 1 (Xbp1) splicing was analyzed as described by Vecchi
et al.17 Primer sequences are listed in Supplementary Table 1.
The Hamp oligos detects total Hamp mRNA (Hamp1 and Hamp2
mRNA).
Western Blot Analyses
For the FPN1 assay, mouse liver specimens were homoge-
nized in lysis buffer (150 mmol/L NaCl, 10 mmol/L Tris,
pH ¼ 8, 1 mmol/L EDTA, 0.5% Triton X-100) containing 1:100
protease inhibitor cocktail (Sigma-Aldrich). After centrifugation
at 13,000 # g at 4!C for 15 minutes, the supernatant was
collected and the protein concentration was assayed by the
Bradford method. A total of 60 mg of liver extracts were loaded
without boiling on 10% acrylamide gels with Laemmli sample
buffer, and run in sodium dodecyl sulfate–polyacrylamide gel
electrophoresis buffer.
Membranes were probedwith speciﬁc antibodies: rabbit anti-
FPN1 (1:1000; Alpha Diagnostic, Inc, San Antonio, TX), as previ-
ously reported,23 andmouseanti-tubulin (1:3000; Sigma-Aldrich),
followed by appropriate horseradish-peroxidase–conjugated
secondary antibodies. Western blot analysis was perfor-
med by Western Lightning Ultra substrate (PerkinElmer,
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Waltham, MA) according to the manufacturer’s instructions.
Chemiluminescence was detected and quantiﬁed using the
Molecular Imager ChemiDoc XRSþ with Image Lab Software
(Bio-Rad).
Cell Cultures and Primary Hepatocyte
Isolation
Human hepatoma HepG2 cells were cultured in Modiﬁed
Eagle’s Medium (MEM) (containing 1 g/L glucose), supple-
mented with 1 mmol/L glutamine, 100 U/mL penicillin, 100 mg/
mL streptomycin, and 10% heat-inactivated fetal bovine serum,
in a 5% CO2 atmosphere at 37!C.
Mouse primary hepatocytes from 8- to 10-week-old male
C57BL/6Crl mice were isolated as previously described.21
HepG2 cells and mouse primary hepatocytes were incu-
bated for 8 hours in the presence of 1 mmol/L of 8Br cAMP
(Sigma-Aldrich) or for 6 hours in the presence of 100 nmol/L
of glucagon (Sigma-Aldrich), both in 2% fetal bovine serum
culture medium.
Plasmids, Small Interfering RNAs,
Transfection, and Luciferase Assay
Hepcidin promoter construct, plasmid encoding Flag-tagged
CREB3L3-N (the active form of the factor), CREB3L3 small
interfering RNA (siRNA) transfection, and luciferase analysis
have been reported elsewhere.17 Plasmid encoding peroxi-
some proliferator-activated receptor gamma coactivator 1-a
(PPARGC1A) was kindly provided by Dr Chang Liu (Nanjing,
China). PPARGC1A siRNA were obtained from Invitrogen (Life
Technologies Italia, Monza, Italy) (PPARGC1AHSS116799).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was described
elsewhere17 with the following modiﬁcations. Brieﬂy, HepG2
cells were transfected using X-tremeGENE transfection reagent
(Roche Applied Science, Milan, Italy) with plasmid encoding
Flag-tagged CREB3L3-N. Forty-eight hours after transfection,
cells were treated with 1 mmol/L 8Br cAMP for 8 hours and
ﬁxed for formaldehyde cross-linking and ChIP. Protein–DNA
complexes were immunoprecipitated overnight using the
following antibodies: anti-Flag (Sigma-Aldrich), anti-PPARGC1A
(anti-PGC1A; Santa Cruz Biotechnology, Dallas, TX), or anti-
green ﬂuorescent protein (GFP) (Abcam, Cambridge, UK) as
negative control.
Statistical Analyses
All data were controlled for normal distribution
(Kolmogorov–Smirnov and Shapiro–Wilk tests). When com-
paring a variable in 2 groups, a paired t test or the
Wilcoxon–Mann–Whitney test was used, depending on the
presence or absence of normal data distribution and/or small
sample size. When making multiple statistical comparisons on a
single data set, for normally distributed data a 1-way analysis
of variance with the Tukey or Dunnett post hoc tests,
depending on the presence or absence of homoscedasticity, was
used. For skewed data, the Kruskal–Wallis test was used. In all
statistical analyses, a P value less than .05 was considered
signiﬁcant. Data presented in Figures are mean % SEM. All
analyses were conducted using Prism 5 for mac OS X version
5.0a software (GraphPad Software, Inc, La Jolla, CA).
Results
In starving mice, phosphoenolpyruvate carboxykinase
1 (Pck1) mRNA, known to be readily responsive to gluco-
neogenic stimuli, rapidly increased at 2 hours (Figure 1A),
whereas Hamp mRNA increased at 5 hours, in concomitance
with a marked serum glucose decrease, and remained
increased for up to 48 hours (Figure 1B). In addition, serum
hepcidin showed a sharp increase at 5 hours, although
slightly decreased at later time points (Figure 1C). Hamp in-
duction led to a decrease of serum iron, and a progressive
increase of serum ferritin and iron content in the spleen and
the liver (Table 1). In agreement with the hepcidin model of
iron regulation, which implies a post-translational down-
regulation of ferroportin protein by hepcidin, hepatic Fpn1
mRNA was unchanged (Figure 1D) whereas FPN1 protein
was degraded in a time-dependent manner starting at
5 hours’ starvation (Figure 1E and F). A visible ferroportin
down-regulation in the spleen was not detected (data not
shown). As discussed earlier, the main stimuli for hepcidin
transcription in vivo are increased serum and hepatic iron,24
and cytokines produced during inﬂammation and infection,
particularly interleukin 6 (IL6),25 IL22,26 tumor necrosis
factor-a,27 and ER stress.17 In mice undergoing prolonged
starvation, we were unable to detect up-regulation of cyto-
kines such as IL6 and tumor necrosis factor-a, whereas IL22
actually was depressed by food withdrawal (Supplementary
Figure 1A–C). IL1b was induced by short-term fasting but
returned to normal at 48 hours (Supplementary Figure 1D),
when hepcidin mRNA expression was still increased mark-
edly. Similar negative results were found when analyzing
inﬂammation marker C-reactive protein (Crp) mRNA
(Supplementary Figure 1E) and ER stress markers (namely,
Xbp1 mRNA splicing; Supplementary Figure 1F). To address
whether hypoferremia in starving mice was caused by lower
iron intake associatedwith food deprivation, we studiedmice
premaintained on an iron-deprived diet for 1 week. After the
iron-deﬁcient diet, this group of mice showed normal serum
iron levels (Figure 2A), but almost halved spleen iron stores
compared with fed mice maintained on an iron-balanced diet
(Figure 2B), suggesting amarked iron redistribution from the
storage site toward the bloodstream to sustain red cell pro-
duction and maintain normal hemoglobin levels (Figure 2C).
However, even under this circumstance, starvation led to a
progressive decrease of serum iron (Figure 2A). Moreover,
hepcidin mRNA expression, although depressed in control
mice (iron-deﬁcient group) likely because of the latent iron-
deﬁciency state and active marrow activity, still dramatically
was induced by starvation (Figure 2D). Activation of hepcidin
and perturbation of iron homeostasis during starvation-
induced gluconeogenesis also was found in other tested
mouse strains, such as BALB/c (Supplementary Figure 2A–C)
or 129S2 (Supplemental Figure 2D–F). Overall, these data
suggested that, in starving mice, stimuli that are independent
of inﬂammation and/or stress may be responsible for hep-
cidin induction.
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To identify the molecular basis for this novel hepcidin
regulatory mechanism, we used an in vitro approach.
The hepatic expression of genes encoding gluconeogenic
enzymes, such as PCK1, is regulated by a network of tran-
scription factors and cofactors, including CREB proteins28,29
and PPARGC1A.30 We recently found that a member of the
CREB family, CREBH, is engaged constitutively on the hep-
cidin promoter and readily transactivates it during ER
stress.17 Both Ppargc1a and Creb3l3 mRNA are induced
by hepatic gluconeogenesis in vivo during starvation
(Figure 3A and B). We hypothesized that CREBH is a target
for PPARGC1A coactivation during hepcidin induction by
active gluconeogenesis. In line with this hypothesis,
PPARGC1A silencing in HepG2 cells led to a 60% decrease of
hepcidin mRNA expression, similar to the effect obtained by
CREB3L3 knockdown (Figure 3C).
Gluconeogenesis induced by food deprivation involves
cAMP as the main intracellular second messenger in
response to hormonal stimuli.31,32 HepG2 cells exposed to
8Br cAMP, a cAMP analog, showed a signiﬁcant increase of
both PCK1 and HAMP mRNA in a time-dependent manner
(Figure 4A). A similar trend of hepcidin activation also was
found in primary hepatocytes exposed to either glucagon
or 8Br cAMP. Both treatments induced Pck1 and Hamp
mRNA expression in cultured hepatocytes, although Hamp
response was signiﬁcantly but appreciably lower than in
HepG2 cells (Figure 4B). Hepcidin stimulation by 8Br
cAMP in HepG2 cells transfected with siRNA for either
Figure 1. In vivo time
course of hepcidin and
ferroportin expression in
mice during starvation. (A)
Real-time qRT-PCR anal-
ysis of Pck1 mRNA and (B)
Hamp mRNA expression
relative to housekeeping
Rpl19 mRNA in C57BL/6
mice fed a standard
diet (white bar) or starved
for the indicated time
periods (gray bars). (C)
Enzyme-linked immunosor-
bent assay quantification of
serum hepcidin levels. (D)
Fpn1 mRNA expression
relative to housekeeping
Rpl19 mRNA. (E) Western
blot analysis of FPN1 pro-
tein expression in the liver,
with tubulin as loading
control. The arrow in-
dicates the specific FPN1
band, whereas the non-
specific upper band is
owing to the secondary
antibody. (F) Densitometric
quantification of FPN1
protein expression relative
to tubulin. Results are
mean % SEM of 6–8 mice
per group. In Western
blot analysis, 3 represen-
tative mice per group
are shown. For mRNA
expression analysis, mean
control values for the fed
mice group are set to 1. P
values are reported for
comparisons between fed
mice and mice fasted at
each time point. *P < .05,
***P < .001.
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PPARGC1A or CREB3L3 was appreciably lower as
compared with 8Br cAMP-treated control cells (Figure 4C).
A similar effect was documented when we tested the
response of Hamp promoter to 8Br cAMP in the presence
of PPARGC1A or CREB3L3 siRNAs (Figure 4D). To prove
that PPARGC1A cooperates with CREBH to turn on hepci-
din in response to gluconeogenesis, we assessed if the
coactivator PPARGC1A/CREBH transduces and binds the
hepcidin promoter in response to gluconeogenic stimuli.
Overexpression of PPARGC1A in HepG2 cells led to a sig-
niﬁcant transactivation of the Hamp promoter, indicating
that the transcription factor is involved in hepcidin pro-
moter regulation (Figure 4E). In a previous study we
showed that CREBH constitutively occupies the HAMP
promoter and transactivates it in response to ER stress.17
Here, the ChIP assay showed that, in addition to the known
constitutive hepcidin promoter occupancy by CREBH
(Figure 4F, aFlag, control cells), PPARGC1A also constitu-
tively binds to the same region (Figure 4F, aPGC1A, con-
trol cells). In agreement with the studies reported earlier,
after exposure of HepG2 cells to 8Br cAMP, more CREBH
was stabilized on the HAMP promoter in the presence of
stable PPARGC1A binding (Figure 4F, 8Br cAMP-treated
cells).
In Creb3l3 null mice, in agreement with the in vitro
studies, starvation correctly induced Pck1mRNA (Figure 5A),
but was unable to activate hepcidin mRNA (Figure 5B),
modify serum hepcidin levels (Figure 5C), or cause hypo-
ferremia (Figure 5D). Of note, Ppargc1a mRNA was still
induced by starvation (Figure 5E), but it apparently was
unable to stimulate hepcidin expression in the absence of
CREBH. These data support a role for CREBH in hepcidin
activation by gluconeogenic stimuli in the liver. Interestingly,
serum glucose levels were signiﬁcantly lower in starving
Table 1. In Vivo Effects of Starvation on Biochemical Parameters in Mice
Fed 2-h Fast 5-h Fast 16-h Fast 24-h Fast 48-h Fast
Serum glucose, mg/dL 249.7 % 36.83 276.4 % 29.31 188.0 % 9.09a 193.2 % 13.61a 146.7 % 39.11b 180.7 % 38.53b
Serum iron, mg/dL 136.3 % 3.33 143.6 % 2.85 138.0 % 8.12 84.00 % 2.96b 86.62 % 3.06b 87.08 % 4.41b
Serum ferritin, ng/mL 204.6 % 8.78 190.0 % 25.61 193.5 % 10.78 286.5 % 32.53 240.0 % 12.58 277.0 % 13.58a
Spleen iron, mg/g dry weight 776.1 % 29.31 837.5 % 64.33 706.7 % 27.62 905.2 % 13.66 852.0 % 56.25 1418 % 58.28b
Liver iron, mg/g dry weight 224.3 % 7.39 226.4 % 9.42 214.9 % 11.12 231.3 % 19.73 262.8 % 16.56 367.1 % 26.99b
NOTE. Serum glucose, serum iron, serum ferritin, and tissue iron levels were analyzed in spleen and liver tissue of wild-type
starving and nonstarving mice. Results are mean % SEM of 6–8 mice per group. P values are reported for comparisons
between fed and each time-point fasted mice.
aP < .01.
bP < .001.
Figure 2. Fasting induces
hepcidin gene expression
also in mice premaintained
on an iron-deficient diet.
Eight- to 10-week-old male
C57BL/6Crl mice were fed
an iron-balanced diet or an
iron-deficient diet for 9
days before death (IB and
ID, respectively), or for 6
days before the 24- to 48-
hour starvation period (ID
fast 24-hr and 48 hr). (A)
Serum iron quantification,
(B) spleen iron content, (C)
hemoglobin (Hb) levels, and
(D) HampmRNA expression
relative to housekeeping
Rpl19 mRNA expression.
Results are expressed as
the mean % SEM of 5–6
mice per group. P values
are reported for compari-
sons between the indi-
cated groups. *P < .05,
**P < .01, ***P < .001.
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Creb3l3 null mice as compared with starving wild-type mice
(Table 2). Seemingly, the increase of serum ketone bodies
during starvation was more pronounced in the Creb3l3 null
mice (4.7- to 5.6-fold) as compared with control mice (3.1- to
3.5-fold) (Table 2).
Discussion
Hepcidin is constitutively produced by the liver to
maintain plasma iron levels within a narrow physiologic
range. To do so it senses a variety of physiologic and pat-
hophysiologic stimuli that tend to alter blood iron levels, and
responds by inhibiting ferroportin, the main iron-exporter in
mammals.33 In this study we showed that hepcidin is regu-
lated transcriptionally also by gluconeogenic signals through
PPARGC1A/CREBH. Induction of this regulatory pathway in
a classic model of insulin resistance/activated gluconeo-
genesis, ie, starvation, leads to tissue iron retention and
circulatory iron deﬁciency. Hypoferremia is clearly second-
ary to increased tissue iron retention after hepcidin induc-
tion and not to reduced food iron intake because it still is
preserved in mice premaintained on an iron-deprived diet
(Figure 2). Activation of hepcidin and perturbation of iron
homeostasis during starvation-induced gluconeogenesis
seem to represent a general defensive response in rodents
because it was found in other tested mouse strains. However,
differences in terms of the time course of hepcidin induction
and the extent of iron status modiﬁcations were detected
clearly among various starving mice strains. This could be
explained by the fact that both the gluconeogenic response/
gluconeogenic gene expression and iron status/iron gene
expression may vary appreciably among mouse strains, as
also documented by the signiﬁcantly higher expression of the
Pck1 gene in C57BL/6 mice (an optimal mouse model for
studying gluconeogenesis/insulin resistance34,35 and the
model that most closely parallels the gluconeogenic response
to starvation seen in human beings) as compared with
129S2, BALB/c, and Creb3l3 null mice (which actually
display a mixed genetic background of 129S1, 129X1,
C57BL/6, FVB/N). A close look at the time course induction
of Pck1/Hamp (Figure 1A and B) and Ppargc1a/Creb3l3
RNAs (Figure 3A and B) suggests that the initial 5-hour burst
of Hamp transcription largely depends on increased Creb3l3
expression. Later, the increase in Ppargc1A expression likely
sustains hepcidin transcription by enhancing and further
stabilizing CREBH binding on the Hamp promoter (Figure 4F,
ChIP study). We were able to reproduce the effect of star-
vation in vitro, in a hepatoma cell line and cultured primary
hepatocytes, using different gluconeogenic stimuli
(Figure 4). However, the Hamp gene response to gluconeo-
genic signals in primary hepatocytes was lower than in
hepatoma cells. This may depend on the fact that in primary
hepatocytes the gluconeogenic signals may be attenuated, as
indicated by the lower Pck1 induction in primary hepato-
cytes exposed to 8Br cAMP as compared with HepG2 cells
(Figure 4B vs A), and/or that additional factors essential for
the hepcidin transcriptional machinery are lost in primary
hepatocytes after the disruption of liver architecture/
microenvironment.
The newly identiﬁed regulatory pathway links glucose
and iron metabolism in the liver and identiﬁes hepcidin, the
iron hormone, as a gluconeogenic sensor.
Figure 3. Ppargc1a and Creb3l3 are induced by starvation
and are involved in hepcidin expression. (A) Real-time qRT-
PCR analysis of Ppargc1a mRNA and (B) Creb3l3 mRNA
expression in liver of C57BL/6 mice fed an iron-standard diet
(white bar) and starved for the indicated time points (gray
bars). (C) Basal expression of HAMP mRNA in HepG2 cells
transfected with siRNAs against PPARGC1A, CREB3L3, or
both. Results are mean % SEM of 6–8 mice per group or 3–4
independent experiments each repeated in triplicate. Mean
control values for the fed mice group for in vivo experiments
or unspecific (US) RNA interference (RNAi) for in vitro ex-
periments are set to 1 and are normalized relative to house-
keeping Rpl19 mRNA. P values are reported for comparisons
between control and treated cells, or between indicated
groups. *P < .05, **P < .01, ***P < .001.
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PPARGC1A is a transcriptional coactivator that regulates
the genes involved in energy metabolism. During starvation,
PPARGC1A readily is activated to turn on the gluconeogenic
machinery, but also to stimulate mitochondrial bio-
genesis and respiration,36 which are essential to support the
increased energy demands. Interestingly, in osteoclasts,
mitochondrial biogenesis involves CREB/PPARGC1A pro-
teins, but requires iron uptake and supply to mitochondrial
respiratory proteins.37 Here, we found that PPARGC1A
constitutively occupies the hepcidin promoter and, in
response to gluconeogenic stimuli, stabilizes CREBH
binding and transactivates HAMP promoter. CREBH is an
ER stress–associated liver-speciﬁc transcription factor origi-
nally involved in the induction of acute-phase response genes
(such as serumamyloidprotein andC-reactive protein38), and
subsequently has been found to activate the transcription of
HAMP.17 Based on recent publications and this report, CREBH
now emerges as a key metabolic regulator in the liver: it is
activated by fatty acids and PPARa,39,40 and regulates the
expression of genes involved in hepatic lipogenesis, fatty acid
Figure 4. Hepcidin is induced by gluconeogenic signals through PPARGC1A/CREBH. (A) HepG2 cells were cultured in the
presence of a cAMP analog (8Br cAMP) and analyzed at different time points for PCK1 and HAMP mRNA expression by real-
time qRT-PCR. (B) Pck1 and Hamp mRNA expression in primary mouse hepatocytes isolated from C57BL/6 mice and
exposed to glucagon or 8Br cAMP. (C) HAMP mRNA expression and (D) Hamp-promoter luciferase activity in HepG2 cells
after silencing of PPARGC1A and CREB3L3. (E) Hamp-promoter luciferase activity in HepG2 cells transfected with control
plasmid (empty) or construct encoding PPARGC1A protein. (F) ChIP assay of HepG2 cells transfected with Flag-tagged
CREB3L3-N vector and exposed to 8Br cAMP. CREBH (aFlag) and PPARGC1A (aPGC1A) occupancy of CREBH site on
hepcidin endogenous promoter was evaluated by real-time qRT-PCR and expressed as a percentage of the input signal. aGFP
(green fluorescent protein) antibody is used as control, unrelated antibody. Results are mean % SEM of 3–4 independent
experiments, each repeated in triplicate. For mRNA and luciferase analysis, mean control values are set to 1. ChIP data are
mean % SEM representative of 2 separate experiments. P values are reported for comparisons (A and B) between control and
treated cells, (C–E) between indicated groups, or between aGFP and specific antibodies. *P < .05, **P < .01, ***P < .001.
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oxidation, and lipolysis under metabolic stress.20 Interestingly,
CREBH also has been found to transcriptionally regulate Pck1
and glucose-6-phosphatase, the critical genes in hepatic gluco-
neogenic response.41 Here, we report that CREBH is engaged
constitutively on the hepcidin promoter to sense metabolic
gluconeogenic stress and modify, accordingly, iron trafﬁc. Of
note is that starvingCreb3l3nullmice showreducedglucose and
increased ketone body output.
Adaptation to starvation is essential for species sur-
vival.42 Seemingly, defense against pathogens represents a
priority in species evolution. The liver, as the main source for
hepcidin, seems to play a central role in both processes.
During infection, hepcidin limits vital iron that is needed
by invading microorganisms, thus contributing to host
defense.25 During prolonged starvation, hepcidin likely pre-
serves tissue iron and helps to maintain energy balance
Figure 5. Starvation fails to
induce hepcidin gene
expression in Creb3l3-/-
mice. Eight- to 10-week-old
wild type (WT) or Creb3l3-/-
male mice were starved for
24 or 48 hours before
death. (A) Pck1 mRNA and
(B) Hamp mRNA expres-
sion were assessed by
real-time qRT-PCR. (C)
Enzyme-linked immuno-
sorbent assay quantifica-
tion of serum hepcidin
levels and (D) serum iron
levels. (E) Ppargc1a mRNA
expression in starved mice.
Results are mean% SEM of
6–8 mice per group. (A, B,
and E) Mean control values
for the fed mice group are
set to 1 and are normalized
relative to housekeeping
Rpl19 mRNA. P values are
reported for comparisons
between fed and 24- or
48-hour fasted mice, within
each genotype. *P < .05,
**P < .01, ***P < .001.
Table 2. In Vivo Effects of Starvation on Glucose and Ketone Body Status in Creb3l3 Null Mice
WT Creb3l3 -/-
Fed 24-h Fast 48-h Fast Fed 24-h Fast 48-h Fast
Serum glucose, mg/dL 243.7 % 8.32 146.2 % 26.91a 102.2 % 12.78a 237.6 % 8.26 95.2 % 9.24a 64.8 % 9.41a
Serum ketone bodies, mmol/L 0.54 % 0.13 1.68 % 0.10a 1.88 % 0.24a 0.39 % 0.02 1.85 % 0.17a 2.20 % 0.17a
NOTE. Serum glucose and ketone bodies levels were analyzed in WT and Creb3l3 null mice starved for 24 or 48 hours before
sacrifice. Results are mean % SEM of 6–8 mice per group. P value are reported for comparisons between fed and 24- or
48-hour fasted mice, within each genotype.
aP < .001.
April 2014 Gluconeogenesis and Iron Homeostasis 1067
BA
SI
C
AN
D
TR
AN
SL
AT
IO
NA
L
LI
VE
R
and support gluconeogenesis in the liver (this report). Most
likely, this response originally evolved to protect human
beings during food withdrawal.
Paradoxically, in human disorders associated with food
excess and storage, such as type 2 diabetes, obesity, and the
metabolic syndrome, persistently activated gluconeogenesis
may result in overstimulation of hepcidin, iron accumulation,
and potential damage. Cases of unexplained hepatic iron
excess, characterized by high serum ferritin levels with normal
or subnormal transferrin saturation, and associated with
metabolic abnormalities, originally were reported by Moirand
et al,43 who also introduced the term iron overload-associated
insulin resistance (recently renamed dysmetabolic iron over-
load syndrome). Hepatocellular and/or mesenchymal iron
deposition, usually slight ormild, has been reported since then
in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic
steatohepatitis.44 The clinical relevance of iron excess in these
disorders, in terms of ﬁbrosis development and cancer risk, is
actively debated,45 but increasing data indicate that iron
may sustain disease activity and/or contribute to its pro-
gression.46–49 Interestingly, NAFLD patients with mixed or
mesenchymal iron overload (a pattern of iron deposition
consistent with a “hepcidin-excess model”) seem more likely
to develop ﬁbrosis than those with pure parenchymal iron
deposits (a pattern of iron deposition consistent with a
“hepcidin-deﬁcient model”).47,49 The mechanism of iron
deposition in NAFLD/dysmetabolic iron overload syndrome
likely is multifactorial: sex, diet, disease activity, genetic
background (HFE hemochromatosis gene mutations),
ethnicity, and (micro)inﬂammation all may account for the
variability of both iron excess and its pattern of distribution.
We hypothesize that a fraction of dysmetabolic/NAFLD pa-
tients with normal-low transferrin saturation and mixed/
mesenchymal hepatic iron deposits may represent a subgroup
of patients with prominent insulin resistance and hepcidin
induction via the gluconeogenic PPARGC1A/CREBH-driven
pathway described here. In these patients, hepcidin, depend-
ing on the degree and duration of its induction, may modify
iron trafﬁc locally or systemically and lead, respectively, to
simple hepatic iron retention with marginal systemic re-
ﬂections (ie, mesenchymal/mixed hepatic iron accumulation
with normal or subnormal transferrin saturation), or sub-
stantial tissue iron retention, hypoferremia, and iron-
restricted anemia. Further studies are needed to prove that
the gluconeogenic signal-driven induction of hepcidin in
starving mice also takes place in other instances of activated
gluconeogenesis and insulin resistance, such as diabetes,
obesity, or NAFLD. If so, because of the increasingly recognized
negative effect of iron excess on the progression of these
disorders, the novel regulatory pathway reported here may
offer potential new therapeutic targets to prevent or correct
iron disturbances in common metabolic disorders.
Supplementary Material
Note: To access the supplementary material accompanying
this article, visit the online version of Gastroenterology at
www.gastrojournal.org, and at http://dx.doi.org/10.1053/
j.gastro.2013.12.016.
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Supplementary Figure 1. Hepatic expression of inflammation or ER stress markers in mice during starvation. Total liver mRNA
analysis in liver of C57BL/6 mice fed a standard diet (white bar) and starved for the indicated time points (gray bars). (A–D)
Real-time qRT-PCR analysis of cytokine mRNA expression relative to housekeeping Rpl19 mRNA: (A) Il6, (B) Il22, (C) Tnf, and
(D) Il1b. (E) Crp mRNA expression, as an inflammatory marker, and (F) PCR analysis of Xbp1 mRNA splicing analysis, as an ER
stress marker. Results are mean % SEM of 6–8 mice per group. For mRNA expression analysis, mean control values for the fed
mice group are set to 1. In the Xbp1 splicing analysis, 3 representative mice per group are shown. MW, molecular weight, PC
positive control. P values are reported for comparisons between fed mice and fasted mice at each time point. *P < .05.
1069.e1 Vecchi et al Gastroenterology Vol. 146, No. 4
Supplementary Figure 2. Fasting induces hepcidin gene expression and hypoferremia in vivo in BALB/c and 129S2/SvPas
(129S2) wild-type mice. Eight- to 10-week-old (A–C) BALB/c and (D–F) 129S2/SvPas wild-type mice were fasted for 24-48
hours. Real-time qRT-PCR analysis of (A and D) Pck1 mRNA, (B and E) Hamp mRNA, and (C and F) serum iron in fed and
fasted mice. Results are expressed as the mean % SEM of 6–8 mice per group. For mRNA expression analysis in panels A and
B and in D and E, the mean control values are set to 1 and are normalized relative to housekeeping Rpl19 mRNA. P values are
reported for comparisons between control fed mice and fasted mice. *P < .05, **P < .01, ***P < .001.
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Supplementary Table 1. List of Primers Used for Real-Time qRT-PCR
Accession number Gene name Forward Reverse
Murine oligonucleotides
NM_032541.1 Hamp 50-GCCTGTCTCCTGCTTCTCCT-30 50-GCTCTGTAGTCTGTCTCATCTGTT-30
NM_011044.2 Pck1 50-AACTGTTGGCTGGCTCTC-30 50-GAACCTGGCGTTGAATGC-30
NM_145365.3 Creb3l3 50-GATACCCTGTACCCGGAGGAG-30 50-CGGACAGCAGCAGTTCCTTC-30
NM_008904.2 Ppargc1a 50-CCGTAAATCTGCGGGATGATG-30 50-CAGTTTCGTTCGACCTGCGTAA-30
NM_031168.1 Il6 50-ATGGATGCTACCAAACTGGAT-30 50-TGAAGGACTCTGGCTTTGTCT-30
NM_008361.3 Il1b 50-CCTTTTCGTGAATGAGCAGACAG-30 50-TCTCTTTGAACAGAATGTGCCATG-30
NM_016971.2 Il22 50-ATGAGTTTTTCCCTTATGGGGAC-30 50-GCTGGAAGTTGGACACCTCAA-30
NM_013693.2 Tnf 50-ATGGCCTCCCTCTCATCAGTT-30 50-GGCTACAGGCTTGTCACTCG-30
NM_007768.4 Crp 50-CTGCACAAGGGCTACACTGT-30 50-TCTCCCACCAAAGACTGCTTT-30
NM_009078.2 Rpl19 50-ATGAGTATGCTCAGGCTACAGA-30 50-GCATTGGCGATTTCATTGGTC-30
NM_016917.2 Fpn1 50-AAGACTCCAACATCCGTGAACTT-30 50-GACCCATCCATCTCGGAAAGTG-30
Human oligonucleotides
NM_021175.2 HAMP 50-TGTTTTCCCACAACAGACGGG-30 50-CGCAGCAGAAAATGCAGATGG-30
NM_000981.3 RPL19 5-0GGGCATAGGTAAGCGGAAGG-30 50-TCAGGTACAGGCTGTGATACA-30
NM_032607.1 CREB3L3 50-CCTCTGTGACCATAGACCTGG-30 50-ACGGTGAGATTGCATCGTGG-30
NM_013261.3 PPARGC1A 50-GCTTTCTGGGTGGACTCAAGT-30 50-TCTAGTGTCTCTGTGAGGACTG-30
NM_002591.3 PCK1 50-GCGGCTGAAGAAGTATGA-30 50-GGAACCTGGCATTGAACG-30
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